Short Interest in Bachem Holding AG (OTCMKTS:BCHMF) Grows By 45.2%

Bachem Holding AG (OTCMKTS:BCHMF) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 380,500 shares, an increase of 45.2% from the September 30th total of 262,100 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Bachem Stock Down 11.0%

BCHMF stock opened at $65.00 on Wednesday. The business has a 50 day moving average of $67.29 and a 200-day moving average of $63.89. Bachem has a 12-month low of $65.00 and a 12-month high of $73.00.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on BCHMF. Jefferies Financial Group began coverage on Bachem in a research note on Thursday, September 25th. They issued an “underperform” rating for the company. Deutsche Bank Aktiengesellschaft raised Bachem to a “buy” rating in a research note on Monday, October 27th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold”.

Bachem Company Profile

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs).